Jolie G. Ringash

Toronto, ON M5G2M9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 226 publications

Needs and Preferences for Peer Support and Peer Navigation Among Patients With Head and Neck Cancer: A Cross-Sectional Survey at a Canadian Cancer Centre.

Needs and Preferences for Peer Support and Peer Navigation Among Patients With Head and Neck Cancer: A Cross-Sectional Survey at a Canadian Cancer Centre.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: August 07, 2026

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: February 17, 2026

ASO Visual Abstract: Development and Validation of EsoTIME, a Prognostication Tool for Resected Esophageal and Gastroesophageal Cancer.

ASO Visual Abstract: Development and Validation of EsoTIME, a Prognostication Tool for Resected Esophageal and Gastroesophageal Cancer.

Journal: Annals of surgical oncology

Published: November 14, 2025

Diversity and Experiences of Radiation Oncologists in Canada: A Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion, and Workplace Discrimination-A National Cross-Sectional Electronic Survey.

Diversity and Experiences of Radiation Oncologists in Canada: A Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion, and Workplace Discrimination-A National Cross-Sectional Electronic Survey.

Journal: Current oncology (Toronto, Ont.)

Published: September 19, 2025

Understanding Equity, Diversity, and Inclusion Within Canadian Radiation Oncology Training Programs: A National Survey of Residents and Fellows.

Understanding Equity, Diversity, and Inclusion Within Canadian Radiation Oncology Training Programs: A National Survey of Residents and Fellows.

Journal: Current oncology (Toronto, Ont.)

Published: September 19, 2025

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

Journal: International journal of radiation oncology, biology, physics

Published: August 28, 2025

Risk factors and survival impact of severe radiation-related late toxicities in head and neck cancer-a cohort study.

Risk factors and survival impact of severe radiation-related late toxicities in head and neck cancer-a cohort study.

Journal: Lancet regional health. Americas

Published: May 08, 2025

Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study.

Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study.

Journal: JAMA otolaryngology-- head & neck surgery

Published: April 10, 2025

Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis.

Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis.

Journal: The Laryngoscope

Published: April 04, 2025

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

Journal: The Lancet. Oncology

Published: March 30, 2025

Development and Validation of EsoTIME, a Prognostication Tool for Resected Esophageal and Gastroesophageal Cancer.

Development and Validation of EsoTIME, a Prognostication Tool for Resected Esophageal and Gastroesophageal Cancer.

Journal: Annals of surgical oncology

Published: March 13, 2025

Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.

Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.

Journal: Oral oncology

Published: January 15, 2025

Showing 1-12 of 226

Last Updated: 09/26/2026